We have previously documented decreased levels of MT1 in RA synovial tissue compared with levels in healthy non-RA clinic samples, and we have described how the MT1 receptor is required for melatonin to inhibit TNF-α and IL-1β production [17]. Here, TNF is linked to rheumatoid arthritis.